The Lynx Group

A. Keith Stewart, MB, ChB


Authored Items

Case: Biomarkers in Multiple Myeloma

March 2016, Vol. 5, No. 2 - PMO Live

A protein biomarker predicts response to immunomodulatory drug (IMiD) therapy for multiple myeloma (MM). At PMO Live 2015, A. Keith Stewart, MB, ChB, Consultant, Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, presented a case study illustrating the relative merits of an MM-specific gene panel to test for targetable [ Read More ]

Sign me up!